---
schema_version: "secwatch.filing_event.v1"
accession: "0001396814-24-000120"
form_type: "8-K"
ticker: "PCRX"
cik: "0001396814"
company_name: "Pacira BioSciences, Inc."
filed_at: "2024-09-09T23:59:59+00:00"
generated_at: "2026-05-31T05:52:27.299314+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Pacira board rejects director Laura Brege's resignation after majority withhold vote

## Summary
- Laura Brege received majority withhold votes at 2024 annual meeting; tendered resignation per company policy.
- Independent directors unanimously rejected resignation after considering her qualifications, attendance, and prior support.
- Brege stepped down from HLS Therapeutics board on Aug 7 to address overboarding; remains Pacira director until 2027.

## SEC filing metadata
- accession: 0001396814-24-000120
- form_type: 8-K
- ticker: PCRX
- cik: 0001396814
- company_name: Pacira BioSciences, Inc.
- filed_at: 2024-09-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1396814/000139681424000120/0001396814-24-000120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1396814/000139681424000120/pcrx-20240903.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001396814-24-000120
- JSON: https://secwatch.observer/filing/0001396814-24-000120.json
- Plain text: https://secwatch.observer/filing/0001396814-24-000120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.